Professor Sarah Gilbert, 59, who has a great job in the Covid-19 Astrazeneca Prevention Vaccine Development Campaign Campauzeneca.0: 00/3: 36 South Sansarah Gilbert born in 1962 in a basic family in Northamptonshire, Central Vietnam . Her father was an office worker, the mother was an English teacher. Gilbert's passion for the medicine of Gilbert started to group when she studied at Kettering School. After graduating from the biology at the University of East Anglia, she continued to study a doctor in the Genetics industry at Hull University
. Joining Oxford University in 1994 and became a lecturer in 2004. She became a member of the Jenner Institute of Oxford University. The scientific girl said that the way to take her to the vaccine was a charm
"At first, I went to Oxford to work in a human gene project. Save focus on a specific type of immune response, protecting people from malaria. Therefore, the next step is to create an effective vaccine through this immune response. That's how I continue Close Vaccine ", Mrs. Gilbert said.Sarah Gilbert. (Photo: Telegraph) turned to Gilbert in 2007 when the Wellcome Trust fund decided to sponsor her for the seasonal influenza vaccine development project. At this point, Sarah Gilbert has just completed a long-term desire to set up an in-depth research group of vaccines. With colleagues, Gilbert and the basic platform design colleagues help develop Chadox1 NCOV-19 vaccine Astrazeneca and Oxford later. To do this, Gilbert sought to call the British government funding and aims to create a vaccine for humanity that capable of fighting all strains of influenza viruses
"Right from the beginning We realize that this vaccine will participate in antivirus races, not to compete with other vaccines. We work at college and don't intend to make money from it, "said Gilbert. Before Covid-19 outbreaks, Gilbert's group studied a vaccine against Middle East Respiratory Syndrome (MERS -Cov) Based on Voccine technology.When the NCOV's gene structure is announced in January, Gilbert realizes that can develop Covid-19 vaccine similar to how to do with Mers-Cov. Admire Gilbert because of her vision by the moment Covid-19 began to spread, no one thought it would spread as currently. Meanwhile, Gilbert's group rushed into the study, "January, February, March is crazy. It feels like I spent my life to prepare for this," Gilbert shared and said she had to Working from early morning to late evening during this period. In order to show Mother's research, Gilbert's son all attended the birth industry decided to participate in the test and the results were very optimistic. Vaccine Oxford / Astrazeneca currently becomes the main pillar in the vaccination campaign of many countries. (Photo: Reuters) to April, Oxford's group achieves an agreement with Astrazeneca - Russia / Swedish pharmaceutical company responsible Production and distribution of vaccines with non-profit commitments. According to the agreement, Astrazeneca will sell vaccines developed by Oxford with unreasonable original prices during the pandemic period and keep this preferential price with middle-income countries Vase and low. This helps their vaccines can be distributed at very cheap prices, with only more than 3 USD / dose. " The inventor of this vaccine, I can earn a huge profit. But I refused to receive a vaccine patent. I don't want to exclusive patents because I want to share this technology so that people can produce vaccines, "said Ms. Gilbert sharing. Vaccine Oxford / AstraZeneca also has the advantage of just preserving in Cold temperatures are usually (2-8 degrees C), facilitating transport and storage, even in poor countries. After the period of testing, by the end of 2020, he officially approved using Vaccine Oxford / Astrazeneca. This vaccine then turns distributed to many parts of the world, including Vietnam and becomes the main pillar in the vaccination campaign of many countries at the present time. fit) . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
